Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Choosing the right credit card can unlock amazing bonuses. Explore the options that offer the best rewards for your spending habits.
24,052 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A four-year tax window under SECURE 2.0 lets workers aged 60-63 contribute up to $11,250 a year to a 401(K). Surgeons...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
Coinbase announced a 14% workforce cut to accelerate a lean, AI-native operating model amid ongoing crypto market vol...
HomeServices of America has named Jason Waugh to succeed Vince Leisey as CEO of HSF Affiliates, with a transition set...
A once-sacrosanct pledge to never dump bitcoin treasury holdings is showing cracks as firms explore selling slices to...
Disney beats Q2 expectations, sending Wall Street into a target-upgrade cycle. JPMorgan, Barclays and Guggenheim lift...
A single wall street analyst thinks Tilray could deliver a sizable rally in the coming weeks. This article breaks dow...
Sandisk has surged as AI infrastructure gains grab headlines. But can the rally last? This article lays out 3-year sc...
KeyBanc cut McDonald’s price target to $330 following a quarterly beat, citing softer April results and challenging y...
Qualcomm is betting big on non-phone AI devices, teaming with top AI firms to power wearables that act as autonomous ...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...